{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:35:09Z","timestamp":1793298909443,"version":"4.5.0"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T00:00:00Z","timestamp":1722988800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","ajconline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.amjcard.2024.08.004","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T20:49:30Z","timestamp":1723063770000},"page":"27-36","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["ACE Inhibitor and Angiotensin Receptor Blocker Use During Pregnancy: Data From the ESC Registry Of Pregnancy and Cardiac Disease (ROPAC)"],"prefix":"10.1016","volume":"230","author":[{"given":"Johanna A.","family":"van der Zande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karishma P.","family":"Ramlakhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Prokselj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edison","family":"Mu\u00f1oz-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalia","family":"Baroutidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Lipczynska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edit","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Rutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arie","family":"Franx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6770-3830","authenticated-orcid":false,"given":"Jolien W.","family":"Roos-Hesselink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2024.08.004_bib0001","first-page":"60","article-title":"The use of ACE inhibitor in cardiovascular disease","volume":"38","author":"Nasution","year":"2006","journal-title":"Acta Med Indones"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0002","article-title":"First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension","volume":"11","author":"Chen","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0003","doi-asserted-by":"crossref","first-page":"4572","DOI":"10.2174\/092986712803306411","article-title":"Mechanisms of fetal and neonatal renal impairment by pharmacologic inhibition of angiotensin","volume":"19","author":"Chevalier","year":"2012","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0004","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.jpeds.2015.05.045","article-title":"Renin angiotensin system blocker fetopathy: a midwest pediatric nephrology consortium report","volume":"167","author":"Nadeem","year":"2015","journal-title":"J Pediatr"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0005","doi-asserted-by":"crossref","first-page":"e00644","DOI":"10.1002\/prp2.644","article-title":"Adverse pregnancy outcomes associated with first-trimester exposure to angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers: a systematic review and meta-analysis","volume":"8","author":"Buawangpong","year":"2020","journal-title":"Pharmacol Res Perspect"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0006","doi-asserted-by":"crossref","first-page":"e3453","DOI":"10.1002\/dmrr.3453","article-title":"Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis","volume":"37","author":"Fu","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0007","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehs270","article-title":"Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology","volume":"34","author":"Roos-Hesselink","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0008","doi-asserted-by":"crossref","first-page":"3848","DOI":"10.1093\/eurheartj\/ehz136","article-title":"Pregnancy outcomes in women with cardiovascular disease: evolving trends over 10 years in the ESC Registry of Pregnancy and Cardiac disease (ROPAC)","volume":"40","author":"Roos-Hesselink","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0009","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2020.01.017","article-title":"Obstetric care consensus #10: management of stillbirth: (replaces practice bulletin number 102, March 2009)","volume":"222","author":"Metz","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0010","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/ejhf.501","article-title":"Global cardiac risk assessment in the Registry of Pregnancy and Cardiac disease: results of a registry from the European Society of Cardiology","volume":"18","author":"van Hagen","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0011","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/HJH.0000000000002233","article-title":"Fetotoxic risk of AT1 blockers exceeds that of angiotensin-converting enzyme inhibitors: an observational study","volume":"38","author":"Weber-Schoendorfer","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0012","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1007\/s00204-016-1843-3","article-title":"Risk factors for Down syndrome","volume":"90","author":"Copped\u00e8","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0013","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(18)30311-8","article-title":"Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health","volume":"391","author":"Stephenson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0014","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s10815-022-02451-x","article-title":"Epigenetics of pregnancy: looking beyond the DNA code","volume":"39","author":"Zuccarello","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/j.amjcard.2024.08.004_bib0015","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1469-0705.1996.07020108.x","article-title":"Outcome of singleton pregnancies with severe oligohydramnios in the second and third trimesters","volume":"7","author":"Shipp","year":"1996","journal-title":"Ultrasound Obstet Gynecol"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002914924005794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,10]],"date-time":"2024-10-10T20:21:28Z","timestamp":1728591688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002914924005794"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":15,"alternative-id":["S0002914924005794"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.004","relation":{},"ISSN":["0002-9149"],"issn-type":[{"value":"0002-9149","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ACE Inhibitor and Angiotensin Receptor Blocker Use During Pregnancy: Data From the ESC Registry Of Pregnancy and Cardiac Disease (ROPAC)","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2024.08.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}